Durvalumab with platinum-based chemotherapy, then with or without olaparib, for treating newly diagnosed advanced or recurrent endometrial cancer [ID6317]
In development
Reference number: GID-TA11340
Expected publication date: TBC
NICE has paused the evaluation of durvalumab with platinum-based chemotherapy, then with or without olaparib, for treating newly diagnosed advanced or recurrent endometrial cancer [ID6317] because the company and NHSE have commenced commercial discussions.